Molecular Analysis for Personalized and Targeted Cancer Therapies
At Welmedis, we aim to transform cancer care by developing targeted cancer therapeutics. Using gene and protein expression data from the RGCC target identification pipeline, we identify novel targets for small-molecule therapeutics tailored to specific patient populations. Our innovative approach combines cutting-edge diagnostics and drug development to provide the most effective treatments for specific cancer types.
Pipeline
Our pipeline showcases ongoing research and development projects in the field of targeted cancer therapies. There, you can check their current status and field of indication.
Chemical Drug Discovery
At Welmedis, we drive drug discovery through cutting-edge science and advanced technologies to develop innovative therapies. Our focus is on accelerating preclinical development for targeted cancer treatments. With automation, innovation, and a relentless focus on results, our approach is built for precision. This is where next-gen research meets real-world impact — and it’s just the beginning.
Bioscientific Discovery
Our Bioscience experts lay the important groundwork for chemical drug discovery by identifying cancer-specific gene and protein expression profiles for drug development. Using both human cancer cells grown in classical as well as advanced three-dimensional cultivation systems, we validate promising anti-cancer drugs on protein and cellular levels and investigate new therapeutic approaches. This work drives the discovery of new targets, therapies, and strategies to fight cancer. Explore how we are supporting targeted cancer therapy development.
About
At Welmedis, we’re driven by a single goal: to close the gap between diagnosis and treatment in cancer care.
By combining precision diagnostics with drug development, we’re building a new model for targeted medicine — one that turns scientific discovery into real impact. Find out how that vision is becoming reality.
News
Here, we share the stories behind our science, highlight key milestones, and keep you informed about how we're transforming precision medicine.
-
15. May 2025
Welmedis Announced as Gold Sponsor of the 16th Day of Life Sciences Event
Welmedis is pleased to announce its role as Gold Sponsor of the upcoming 16th Day of Life Sciences, taking place…